Rodolfo Villena - Infectious Diseases

Author Information

Rodolfo Villena is affiliated with the Department of Pediatrics, Faculty of Medicine, Universidad de Chile, and the Infectious Diseases Unit at the Hospital de niños Dr. Exequiel González Cortés in Chile. His research primarily revolves around infectious diseases, with a focus on vaccine development and epidemiology related to meningococcal diseases and SARS-CoV-2.

Research Contributions

Rodolfo Villena has made significant contributions to the field of infectious diseases, particularly in the context of vaccine development and epidemiology in Chile. His work includes research on the impact of the ACWY conjugate vaccine on invasive meningococcal disease in Chile and the safety and immunogenicity of inactivated SARS-CoV-2 vaccines in children and adolescents. Additionally, he has been involved in formulating national action plans and policies concerning vaccine refusal and mandatory vaccination, addressing public health challenges in Chile.

Aliases

Rodolfo Villena is also known by the alias R. Villena in various publications and research contributions.

Publication and Citation Metrics

Metric	Value
Total Papers	18
Total Citations	188
H-index	6

Publications:

Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction

DOI: 10.1016/j.vaccine.2021.11.075

Year: 2022

An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile

DOI: 10.1101/2022.02.15.22270973

Year: 2022

Versión in press ID 3333-ing Pediatric Multisystemic Inflammatory Syndrome Temporarily associated with COVID-19: clinical characteristics and management in a Pediatric Critical Care Unit

DOI:

Year: 2021

[National action plan for the emergence of invasive meningococcal disease in Chile, 2012-2013].

DOI: 10.4067/S0034-98872019000600776

Year: 2019

[Statement from the Immunization Committee of the Chilean Infectious Diseases Society in reference to vaccine refusal and mandatory policy on vaccination].

DOI: 10.32641/rchped.v90i5.526

Year: 2019

Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile.

DOI: 10.1016/j.vaccine.2019.09.050

Year: 2019

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines

DOI: 10.1080/21645515.2018.1458175

Year: 2018

O'Ryan, M. (2018). Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein

DOI:

Year: 2018

[Statement from the Immunization Committee of the Chilean Infectious Diseases Society in reference to vaccine refusal and mandatory policy on vaccination].

DOI: 10.4067/S0716-10182017000600583

Year: 2017

[Result of a model of management of special vaccines].

DOI: 10.4067/S0370-41062017000600723

Year: 2017

What are the Challenges in Genomic and Proteomic Studies?

How do you handle food and water safety?

Can Receptors Be Therapeutic Targets?

What Are the Consequences?

How Are Respiratory Symptoms Diagnosed?

What are Future Directions in Protein Targeting?

What are the challenges in controlling Plasmodium falciparum malaria?

How Do Fungi Infect Hosts?

What are Emerging Viral Threats?

What are the Key Factors in Resource Allocation?

Partnered Content Networks

Relevant Topics